Scarica l'app Stockscreener
6.26
7.75%
0.45
Dopo l'orario di chiusura:
6.20
-0.06
-0.96%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RCEL Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$5.81
Aprire:
$6.24
Volume 24 ore:
240.17K
Relative Volume:
0.83
Capitalizzazione di mercato:
$165.48M
Reddito:
$50.14M
Utile/perdita netta:
$-35.38M
Rapporto P/E:
-4.4714
EPS:
-1.4
Flusso di cassa netto:
$-39.46M
1 W Prestazione:
+17.45%
1M Prestazione:
+21.79%
6M Prestazione:
-30.06%
1 anno Prestazione:
-39.75%
Intervallo 1D:
$5.83
$6.34
Intervallo di 1 settimana:
$5.0327
$6.34
Portata 52W:
$4.71
$14.16
Avita Medical Inc Stock (RCEL) Company Profile
Nome
Avita Medical Inc
Settore
Industria
Telefono
661-568-1317
Indirizzo
28159 AVENUE STANFORD, VALENCIA, CA
Confronta RCEL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
6.26 | 153.59M | 50.14M | -35.38M | -39.46M | -1.40 |
|
ABT
Abbott Laboratories
|
125.83 | 218.75B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.76 | 152.62B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
400.93 | 151.01B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.01 | 117.43B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.91 | 44.76B | 5.54B | 4.18B | 623.10M | 7.00 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-24 | Iniziato | D. Boral Capital | Buy |
| 2024-04-11 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-06-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-03-02 | Iniziato | Piper Sandler | Overweight |
| 2020-08-27 | Iniziato | BofA Securities | Buy |
| 2020-04-21 | Iniziato | Oppenheimer | Outperform |
| 2020-03-03 | Iniziato | BTIG Research | Buy |
Mostra tutto
Avita Medical Inc Borsa (RCEL) Ultime notizie
What drives AVITA Medical Inc. stock priceDynamic growth stocks - Autocar Professional
What analysts say about AVITA Medical Inc. stockRapid wealth creation - Autocar Professional
Is AVITA Medical Inc. a good long term investmentBreakout stock performance - jammulinksnews.com
AVITA Medical Inc. Stock Analysis and ForecastExceptional profit velocity - jammulinksnews.com
Why AVITA Medical Inc. stock attracts strong analyst attentionGrowth Stock Monitor - Newser
Will AVITA Medical Inc. stock benefit from AI tech trendsFree Expert-Led Investment Training - beatles.ru
(RCEL) Trading Signals - news.stocktradersdaily.com
why avita medical inc. stock attracts strong analyst attentionPredictable Return Stock Picks - Newser
What makes AVITA Medical Inc. stock price move sharplyFree Real-Time Stock Data - Newser
How AVITA Medical Inc. stock performs during market volatilityTop ROI Selections - Newser
When Can We Expect A Profit From AVITA Medical, Inc. (NASDAQ:RCEL)? - simplywall.st
Wealth Enhancement Advisory Services LLC Buys 2,564 Shares of Avita Medical Inc. (NASDAQ:RCEL) - Defense World
Ask the analyst: Can ASX growth story turn a profit before it’s too late? - Morningstar
Healthcare Stocks to Watch: Catalyst Pharmaceuticals, AVITA Medical, and Moleculin Biotech. - AInvest
AVITA Medical's High-Stakes Gamble: Can Break-Even Ambitions Outweigh the Debt? - AInvest
(RCEL) Trading Report - news.stocktradersdaily.com
Translational Regenerative Medicine Market Is Booming So - openPR.com
Cantor Fitzgerald Predicts AVITA Medical FY2026 Earnings - MarketBeat
AVITA Medical (RCEL) Receives Continued 'Buy' Rating from D. Bor - GuruFocus
Millennium Management LLC Makes New $426,000 Investment in AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
Avita Medical Says Data Show Recell Reduced Length of Hospital Stay for Burn Patients - MarketScreener
AVITA Medical Highlights Largest Real-World Analysis Demonstrati - GuruFocus
AVITA Medical (RCEL) Reports Significant Benefits of RECELL Technology in Burn Treatment | RCEL Stock News - GuruFocus
AVITA Medical Highlights Largest Real-World Analysis Demonstrating Reduced Hospital Stay with RECELL | RCEL Stock News - GuruFocus
AVITA Medical Highlights Largest Real-World Analysis Demonstrating Reduced Hospital Stay with RECELL - The Manila Times
New Data: Revolutionary RECELL Treatment Cuts Hospital Stays by 35%, Saves Hospitals $300M in Burn Care - Stock Titan
Cantor Fitzgerald maintains Avita Medical at Overweight, $19 target By Investing.com - Investing.com Canada
AVITA Medical's (RCEL) Buy Rating Reaffirmed at D. Boral Capital - MarketBeat
AVITA Medical (NASDAQ:RCEL) Given “Buy” Rating at D. Boral Capital - Defense World
AVITA Medical, Inc. (NASDAQ:RCEL) Short Interest Up 23.9% in May - MarketBeat
RCEL: AVITA Medical Maintains Buy Rating with $19 Price Target | RCEL Stock News - GuruFocus
AVITA Medical Announces First Clinical Publication Demonstrating Accelerated Autograft Readiness with Cohealyx™ - The Manila Times
Avita Medical (RCEL) Unveils Promising Results for Cohealyx in Wound Treatment | RCEL Stock News - GuruFocus
AVITA Medical’s Cohealyx shows promise in wound care - Investing.com
AVITA Medical Announces First Clinical Publication Demonstrating Accelerated Autograft Readiness with Cohealyx™ | RCEL Stock News - GuruFocus
AVITA Medical’s Cohealyx shows promise in wound care By Investing.com - Investing.com UK
Breakthrough: New Clinical Data Shows AVITA's Wound Treatment Heals 4x Faster Than Standard Care - Stock Titan
BNP Paribas Financial Markets Takes Position in AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
Avita Medical Stockholders Approve Key Amendments and Elections - TipRanks
Avita Medical Inc Azioni (RCEL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):